Higher Rates of Hypersensitivity Reactions to Calaspargase Compared With Pegaspargase: A Single Center Retrospective Review
The current administration of Cal-PEG in large cooperative group trials will allow for a postmarketing exploration of the true risk of HSR and associated patient-specific risk factors.
Authors
- Caroline Smith (ORCID: https://orcid.org/0000-0002-9154-6855)
- Naomi Joan Winick (ORCID: https://orcid.org/0000-0002-6636-3870)
- Bianca Patel
- Kyra L. McCarty
- Song Zhang (ORCID: https://orcid.org/0000-0002-9364-4053)
- Ang Gao (ORCID: https://orcid.org/0000-0001-6530-8768)
- Jessica Cox
- Tamra Slone
Institutions
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1002/pbc.31640
- Citations
- 2
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 3.76